Topical Pain Management Therapeutics in Sports Medicine Market

Topical Pain Management Therapeutics in Sports Medicine Market (Product - Gels, Cream, Sprays, and Patches (Drug in Adhesive, Matrix, and Reservoirs); Therapeutic Class - Analgesics (Opioids, Non-opioids), Anesthetics, and Skeletal Muscle Relaxants) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global topical pain management therapeutics in sports medicine market for the historical period 2017–2018 and forecast period 2019–2027, rise in demand for cost-effective and instant pain relief therapeutics by national and international sports players, improved distribution of the pain relief therapeutics in developing countries  and introduction of novel pipeline product are projected to drive the global topical pain management therapeutics in sports medicine market during the forecast period
  • According to the report, the global topical pain management therapeutics in sports medicine market was valued at US$ 1.6 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

To know the scope of our report Get a Sample on Topical Pain Management Therapeutics in Sports Medicine Market

Increase in Incidence of Musculoskeletal Acute Sports Injuries: Key Drivers

  • Growing participation of population in sports activities is leading to increase in number of acute sports injuries, which is expected to drive demand for topical pain management therapeutics in sports medicine market
  • According to the National Health Statistics Reports (NHSR), there were an estimated 10.5 million sports injuries in the U.S. in 2015, of which over 40% (4.2 million) injuries included strains and sprains along with other acute injuries
  • According to the National Health Statistics Reports (NHSR), there were an estimated 10.5 million sports injuries in the U.S. in 2015, of which over 40% (4.2 million) injuries included strains and sprains along with other acute injuries.

Increase in implementation of guidelines promoting topical boost topical pain management therapeutics in sports medicine market growth

  • Various agencies in the U.S. and Europe have laid down guidelines for the treatment of osteoarthritis, which emphasize on the use of topical pain relief products as the first line of treatment
  • These agencies include the American Association of Orthopedic Surgeons (AAOS), the American College of Rheumatology (ACR), the National Institute for Health and Clinical Excellence (NICE, U.K.), the American Pain Society (APS), the European League Against Rheumatism (EULAR), and Osteoarthritis Research Society International (OARSI)
  • The American College of Rheumatology (ACR), in 2012, implemented guidelines, which suggested use of topical capsaicin and topical NSAID with trolamine salicylate for the treatment of osteoarthritis of hand

Get a glimpse of the in-depth analysis through our Report Brochure

Global Topical Pain Management Therapeutics in Sports Medicine Market: Competitive Landscape

  • This report profiles major players in the global topical pain management therapeutics in sports medicine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global topical pain management therapeutics in sports medicine market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global topical pain management therapeutics in sports medicine market are
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer, Inc.
    • Hisamitsu Pharmaceutical Co., Inc.
    • Mayne Pharma Group Limited
    • Sanofi (Chattem, Inc.)
    • GlaxoSmithKline plc
    • Endo Pharmaceuticals Inc.
    • Beiersdorf AG
    • Johnson & Johnson Services, Inc.
    • Topical BioMedics, Inc.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Topical Pain Management Therapeutics in Sports Medicine Market: Key Developments

Key players in the global topical pain management therapeutics in sports medicine market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global topical pain management therapeutics in sports medicine market. A few expansion strategies adopted by players operating in the global topical pain management therapeutics in sports medicine market are:

  • In September 2017, Sanofi India, a subsidiary of Sanofi, announced the launch of Combiflam ICYHOT, a new formulation of its blockbuster drug i.e. Combiflam. The oral blockbuster NSAID would now be offered in topical formulations including gels and sprays. This introduction is expected to enable the company to consolidate its position in the topical pain management sector in the near future
  • In November 2015, Dr. Reddy's Laboratories Ltd., a leading drug manufacturer in India, launched Nise D spray in the country. Nise tablet is a pre-existing and popular tablet formulation in India, which was introduced by Dr. Reddy in a spray form, owing to the rising adoption of the population for spray form of pain relievers.

The report on the global topical pain management therapeutics in sports medicine market discussed individual strategies, followed by company profiles of manufacturers of topical pain management therapeutics in sports medicine. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global topical pain management therapeutics in sports medicine market.

Topical Pain Management Therapeutics in Sports Medicine Market - Outline

There has been an increasing focus on development of new routes of drug administration to provide tailored treatments for patients, without decreasing efficacy of analgesia, in proportion to the progression of the knowledge of pain mechanisms. While acute pain acts as an alarm, chronic pain is a syndrome requiring meticulous selection of analgesic drugs of high bioavailability for long-term use. Such criteria are challenges that topical medications aim to overcome, allowing progressive delivery of active component, maintaining stable plasma levels, with a good safety profile. This review presents recent findings regarding topical formulations of the most widely used drugs for pain treatment, such as nonsteroidal anti-inflammatory agents, anesthetics, and capsaicin, and the role of physical agents as delivery enhancers (phonophoresis and iontophoresis). Although the number of topical agents is limited for use in peripheral conditions, increasing evidence supports the efficacy of these preparations in blocking nociceptive and neuropathic pain. Patient adherence to medical treatment is also a challenge, especially in chronic painful conditions. It is known that reduction of treatment complexity and pill burden are good strategies to increase patient compliance.

Evidence based on empirical practice has suggested that topically applied medications can be almost as effective as those taken orally, with a good safety profile in terms of adverse effects. The ultimate goal that motivates the development of topical preparations is the improvement of patient compliance to medical treatment, by providing efficient pain relief with less central nervous system effects and minimal drug regimen burden.

The medicine or drugs which are applied locally on the area which is being treated is called as topical drugs. ‘Topikos’ in Greek means ‘at a place’. Many creams and ointments which are applied to skin are often called a topical drugs. Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains.

The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants. Topical pain relievers are becoming increasingly popular in sports category owing to their site-specific action, cost-effectiveness, instant pain relief, and availability in the OTC segment

Global Topical Pain Management Therapeutics in Sports Medicine Market - Segmentation

Product

Gels

Creams

Sprays

Patches

  • Drug in Adhesives
  • Matrix
  • Reservoirs
  • Others

Therapeutic Class

Analgesics

  • Opioids
    • Fentanyl
    • Buprenorphine
    • Others
  • Non-opioids
    • Lidocaine
    • Diclofenac
    • Capsaicin
    • Methyl Salicylate
    • Others

Anesthetics

Skeletal Muscle Relaxants

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of topical pain management therapeutics in sports medicine market?

Topical pain management therapeutics in sports medicine market to reach US$ 3,470.3 Mn by 2027

What is the anticipated CAGR of the topical pain management therapeutics in sports medicine market in the forecast period?

Topical pain management therapeutics in sports medicine market is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

What are the key driving factors for the growth of the topical pain management therapeutics in sports medicine market?

Topical pain management therapeutics in sports medicine market is driven by increase in incidence of musculoskeletal acute sports injuries

Which region is expected to project the highest market share in the global topical pain management therapeutics in sports medicine market?

North America accounted for major share of the global topical pain management therapeutics in sports medicine market

Who are the key players in the topical pain management therapeutics in sports medicine market?

Key players in the global topical pain management therapeutics in sports medicine market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Topical Pain Management Therapeutics in Sports Medicine Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Patch Design Technologies: Snapshot Regulatory Scenario, by Region/Globally

        5.2. WHO’s Pain Relief Ladder 

    6. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Product, 2017–2027

            6.2.1. Gels

            6.2.2. Creams

            6.2.3. Patches

                6.2.3.1. Drug in Adhesives

                6.2.3.2. Matrix

                6.2.3.3. Reservoirs

                6.2.3.4. Others

        6.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product

    7. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Therapeutic Class

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Therapeutic Class, 2017–2027

            7.2.1. Analgesics

                7.2.1.1. Opioids

                    7.2.1.1.1. Fentanyl

                    7.2.1.1.2. Buprenorphine

                    7.2.1.1.3. Others

                7.2.1.2. Non-opioids

                    7.2.1.2.1. Lidocaine

                    7.2.1.2.2. Diclofenac

                    7.2.1.2.3. Capsaicin 

                    7.2.1.2.4. Methyl Salicylate 

                    7.2.1.2.5. Others

            7.2.2. Anesthetics

            7.2.3. Skeletal Muscle Relaxants

        7.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class

    8. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region

    9. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

            9.2.1. Gels

            9.2.2. Creams

            9.2.3. Patches

                9.2.3.1. Drug in Adhesives

                9.2.3.2. Matrix

                9.2.3.3. Reservoirs

                9.2.3.4. Others

        9.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

            9.3.1. Analgesics

                9.3.1.1. Opioids

                    9.3.1.1.1. Fentanyl

                    9.3.1.1.2. Buprenorphine

                    9.3.1.1.3. Others

                9.3.1.2. Non-opioids

                    9.3.1.2.1. Lidocaine

                    9.3.1.2.2. Diclofenac

                    9.3.1.2.3. Capsaicin 

                    9.3.1.2.4. Methyl Salicylate 

                    9.3.1.2.5. Others

            9.3.2. Anesthetics

            9.3.3. Skeletal Muscle Relaxants

        9.4. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

            9.5.1. By Product

            9.5.2. By Therapeutic Class

            9.5.3. By Country

    10. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

            10.2.1. Gels

            10.2.2. Creams

            10.2.3. Patches

                10.2.3.1. Drug in Adhesives

                10.2.3.2. Matrix

                10.2.3.3. Reservoirs

                10.2.3.4. Others

        10.3. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

            10.3.1. Analgesics

                10.3.1.1. Opioids

                    10.3.1.1.1. Fentanyl

                    10.3.1.1.2. Buprenorphine

                    10.3.1.1.3. Others

                10.3.1.2. Non-opioids

                    10.3.1.2.1. Lidocaine

                    10.3.1.2.2. Diclofenac

                    10.3.1.2.3. Capsaicin 

                    10.3.1.2.4. Methyl Salicylate 

                    10.3.1.2.5. Others

            10.3.2. Anesthetics

            10.3.3. Skeletal Muscle Relaxants

        10.4. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe 

        10.5. Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

            10.5.1. By Product

            10.5.2. By Therapeutic Class

            10.5.3. By Country/Sub-region

    11. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

            11.2.1. Gels

            11.2.2. Creams

            11.2.3. Patches

                11.2.3.1. Drug in Adhesives

                11.2.3.2. Matrix

                11.2.3.3. Reservoirs

                11.2.3.4. Others

        11.3. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

            11.3.1. Analgesics

                11.3.1.1. Opioids

                    11.3.1.1.1. Fentanyl

                    11.3.1.1.2. Buprenorphine

                    11.3.1.1.3. Others

                11.3.1.2. Non-opioids

                    11.3.1.2.1. Lidocaine

                    11.3.1.2.2. Diclofenac

                    11.3.1.2.3. Capsaicin 

                    11.3.1.2.4. Methyl Salicylate 

                    11.3.1.2.5. Others

            11.3.2. Anesthetics

            11.3.3. Skeletal Muscle Relaxants

        11.4. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific 

        11.5. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

            11.5.1. By Product

            11.5.2. By Therapeutic Class

            11.5.3. By Country/Sub-region

    12. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

            12.2.1. Gels

            12.2.2. Creams

            12.2.3. Patches

                12.2.3.1. Drug in Adhesives

                12.2.3.2. Matrix

                12.2.3.3. Reservoirs

                12.2.3.4. Others

        12.3. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

            12.3.1. Analgesics

                12.3.1.1. Opioids

                    12.3.1.1.1. Fentanyl

                    12.3.1.1.2. Buprenorphine

                    12.3.1.1.3. Others

                12.3.1.2. Non-opioids

                    12.3.1.2.1. Lidocaine

                    12.3.1.2.2. Diclofenac

                    12.3.1.2.3. Capsaicin 

                    12.3.1.2.4. Methyl Salicylate 

                    12.3.1.2.5. Others

            12.3.2. Anesthetics

            12.3.3. Skeletal Muscle Relaxants

        12.4. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America 

        12.5. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

            12.5.1. By Product

            12.5.2. By Therapeutic Class

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.3. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

            13.3.1. Gels

            13.3.2. Creams

            13.3.3. Patches

                13.3.3.1. Drug in Adhesives

                13.3.3.2. Matrix

                13.3.3.3. Reservoirs

                13.3.3.4. Others

        13.4. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

            13.4.1. Analgesics

                13.4.1.1. Opioids

                    13.4.1.1.1. Fentanyl

                    13.4.1.1.2. Buprenorphine

                    13.4.1.1.3. Others

                13.4.1.2. Non-opioids

                    13.4.1.2.1. Lidocaine

                    13.4.1.2.2. Diclofenac

                    13.4.1.2.3. Capsaicin 

                    13.4.1.2.4. Methyl Salicylate 

                    13.4.1.2.5. Others

            13.4.2. Anesthetics

            13.4.3. Skeletal Muscle Relaxants

        13.5. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa 

        13.6. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

            13.6.1. By Product

            13.6.2. By Therapeutic Class

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2018

        14.3. Company Profiles

            14.3.1. Teva Pharmaceutical Industries Ltd.

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Financial Overview

                14.3.1.3. Strategic Overview

                14.3.1.4. SWOT Analysis

            14.3.2. Pfizer, Inc.  

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Financial Overview

                14.3.2.3. Strategic Overview

                14.3.2.4. SWOT Analysis

            14.3.3. Hisamitsu Pharmaceutical Co., Inc.  

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Financial Overview

                14.3.3.3. Strategic Overview

                14.3.3.4. SWOT Analysis

            14.3.4. Mayne Pharma Group Limited

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Financial Overview

                14.3.4.3. Strategic Overview

                14.3.4.4. SWOT Analysis

            14.3.5. Chattem, Inc.

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Financial Overview

                14.3.5.3. Strategic Overview

                14.3.5.4. SWOT Analysis

            14.3.6. GlaxoSmithKline plc.

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Financial Overview

                14.3.6.3. Strategic Overview

                14.3.6.4. SWOT Analysis

            14.3.7. Endo Pharmaceuticals Inc.

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Financial Overview

                14.3.7.3. Strategic Overview

                14.3.7.4. SWOT Analysis

            14.3.8. Beiersdorf AG

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Financial Overview

                14.3.8.3. Strategic Overview

                14.3.8.4. SWOT Analysis

            14.3.9. Janssen Global Services, LLC 

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Financial Overview

                14.3.9.3. SWOT Analysis

            14.3.10. Topical BioMedics, Inc.

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Strategic Overview

                14.3.10.3. SWOT Analysis

    List of Tables

    Table 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    Table 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Region, 2017–2027

    Table 08: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

    Table 09: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 10: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 11: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 12: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 13: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 14: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    Table 15: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

    Table 16: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 17: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 18: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 19: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 20: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 21: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    Table 22: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

    Table 23: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 24: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 25: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 26: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 27: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 28: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    Table 29: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

    Table 30: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 31: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 32: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 33: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 34: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 35: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    Table 36: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

    Table 37: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

    Table 38: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

    Table 39: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

    Table 40: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

    Table 41: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

    Table 42: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

    List of Figures

    Figure 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn), CAGR and Share (%), by Geography, 2018 and 2027

    Figure 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, 2017–2027

    Figure 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018

    Figure 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018

    Figure 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018

    Figure 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gels, 2017–2027

    Figure 08: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Creams, 2017–2027

    Figure 09: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Sprays, 2017–2027

    Figure 10: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Patches, 2017–2027

    Figure 11: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027

    Figure 12: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class , 2018 and 2027

    Figure 13: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Analgesics, 2017–2027

    Figure 14: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anesthetics, 2017–2027

    Figure 15: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skeletal Muscle Relaxants, 2017–2027

    Figure 16: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027

    Figure 17: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018 and 2027 

    Figure 18: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region, 2017–2027

    Figure 19: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 20: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027

    Figure 21: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

    Figure 22: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 23: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

    Figure 24: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

    Figure 25: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

    Figure 26: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 27: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

    Figure 28: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

    Figure 29: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 30: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

    Figure 31: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

    Figure 32: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

    Figure 33: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 34: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

    Figure 35: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

    Figure 36: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 37: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

    Figure 38: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

    Figure 39: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

    Figure 40: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 41: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

    Figure 42: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

    Figure 43: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 44: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

    Figure 45: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

    Figure 46: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

    Figure 47: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 48: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

    Figure 49: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

    Figure 50: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

    Figure 51: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

    Figure 52: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

    Figure 53: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

    Figure 54: Global Topical Pain Management Therapeutics in Sports Medicine Market Share (%) & Market Share Range (%), by Company, 2016 

Copyright © Transparency Market Research, Inc. All Rights reserved